Literature DB >> 12543708

The enzymes, regulation, and genetics of bile acid synthesis.

David W Russell1.   

Abstract

The synthesis and excretion of bile acids comprise the major pathway of cholesterol catabolism in mammals. Synthesis provides a direct means of converting cholesterol, which is both hydrophobic and insoluble, into a water-soluble and readily excreted molecule, the bile acid. The biosynthetic steps that accomplish this transformation also confer detergent properties to the bile acid, which are exploited by the body to facilitate the secretion of cholesterol from the liver. This role in the elimination of cholesterol is counterbalanced by the ability of bile acids to solubilize dietary cholesterol and essential nutrients and to promote their delivery to the liver. The synthesis of a full complement of bile acids requires 17 enzymes. The expression of selected enzymes in the pathway is tightly regulated by nuclear hormone receptors and other transcription factors, which ensure a constant supply of bile acids in an ever changing metabolic environment. Inherited mutations that impair bile acid synthesis cause a spectrum of human disease; this ranges from liver failure in early childhood to progressive neuropathy in adults.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543708     DOI: 10.1146/annurev.biochem.72.121801.161712

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  556 in total

1.  Engineered three-dimensional liver mimics recapitulate critical rat-specific bile acid pathways.

Authors:  Christopher J Detzel; Yeonhee Kim; Padmavathy Rajagopalan
Journal:  Tissue Eng Part A       Date:  2010-12-19       Impact factor: 3.845

Review 2.  Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.

Authors:  Paul A Dawson; Melissa L Hubbert; Anuradha Rao
Journal:  Biochim Biophys Acta       Date:  2010-06-09

3.  Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.

Authors:  Johanna H M Stroeve; Gemma Brufau; Frans Stellaard; Frank J Gonzalez; Bart Staels; Folkert Kuipers
Journal:  Lab Invest       Date:  2010-06-07       Impact factor: 5.662

4.  FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase.

Authors:  Alaric Falcon; Holger Doege; Amy Fluitt; Bernice Tsang; Nicki Watson; Mark A Kay; Andreas Stahl
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-06-08       Impact factor: 4.310

5.  X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C.

Authors:  Owen M Siggs; Bernd Schnabl; Bill Webb; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

6.  FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.

Authors:  Dong-Ju Shin; Timothy F Osborne
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

Review 7.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 8.  The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism.

Authors:  Folkert Kuipers; Thierry Claudel; Ekkehard Sturm; Bart Staels
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

9.  Small Heterodimer Partner Regulates Dichotomous T Cell Expansion by Macrophages.

Authors:  Sayyed Hamed Shahoei; Young-Chae Kim; Samuel J Cler; Liqian Ma; Sayeepriyadarshini Anakk; Jongsook K Kemper; Erik R Nelson
Journal:  Endocrinology       Date:  2019-07-01       Impact factor: 4.736

10.  27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.

Authors:  Qian Wu; Tomonori Ishikawa; Rosa Sirianni; Hao Tang; Jeffrey G McDonald; Ivan S Yuhanna; Bonne Thompson; Luc Girard; Chieko Mineo; Rolf A Brekken; Michihisa Umetani; David M Euhus; Yang Xie; Philip W Shaul
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.